Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.

Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, Verhoeven JS, Christiaens MR, Vandenberghe J, Vandenbulcke M, Sunaert S.

J Clin Oncol. 2012 Jan 20;30(3):274-81. doi: 10.1200/JCO.2011.36.8571. Epub 2011 Dec 19.

PMID:
22184379
2.

Diffusion tensor MRI of chemotherapy-induced cognitive impairment in non-CNS cancer patients: a review.

Deprez S, Billiet T, Sunaert S, Leemans A.

Brain Imaging Behav. 2013 Dec;7(4):409-35. doi: 10.1007/s11682-012-9220-1. Review.

PMID:
23329357
3.

Chemobrain: a systematic review of structural and functional neuroimaging studies.

Simó M, Rifà-Ros X, Rodriguez-Fornells A, Bruna J.

Neurosci Biobehav Rev. 2013 Sep;37(8):1311-21. doi: 10.1016/j.neubiorev.2013.04.015. Epub 2013 May 6. Review.

PMID:
23660455
4.

An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.

Cheung YT, Tan EH, Chan A.

Support Care Cancer. 2012 Jul;20(7):1361-75. doi: 10.1007/s00520-012-1445-4. Epub 2012 Apr 5. Review.

PMID:
22476439
5.

Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.

Jim HS, Phillips KM, Chait S, Faul LA, Popa MA, Lee YH, Hussin MG, Jacobsen PB, Small BJ.

J Clin Oncol. 2012 Oct 10;30(29):3578-87. doi: 10.1200/JCO.2011.39.5640. Epub 2012 Aug 27. Review.

6.

Chemotherapy-related cognitive dysfunction.

Wefel JS, Schagen SB.

Curr Neurol Neurosci Rep. 2012 Jun;12(3):267-75. doi: 10.1007/s11910-012-0264-9. Review. Erratum in: Curr Neurol Neurosci Rep. 2012 Jun;12(3):340.

PMID:
22453825
7.

Cognitive Deficits in Breast Cancer Survivors After Chemotherapy and Hormonal Therapy.

Frank JS, Vance DE, Triebel KL, Meneses KM.

J Neurosci Nurs. 2015 Dec;47(6):302-12. doi: 10.1097/JNN.0000000000000171. Review.

PMID:
26447567
8.

Integrating imaging findings in evaluating the post-chemotherapy brain.

Pomykala KL, de Ruiter MB, Deprez S, McDonald BC, Silverman DH.

Brain Imaging Behav. 2013 Dec;7(4):436-52. doi: 10.1007/s11682-013-9239-y. Review.

PMID:
23828813
9.

Brain vulnerability to chemotherapy toxicities.

Ahles TA.

Psychooncology. 2012 Nov;21(11):1141-8. doi: 10.1002/pon.3196. Epub 2012 Oct 1. Review.

10.

Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review.

Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C.

Cancer Treat Rev. 2012 Nov;38(7):926-34. doi: 10.1016/j.ctrv.2012.05.002. Epub 2012 Jun 2. Review.

PMID:
22658913
11.

Functional MRI studies in non-CNS cancers.

de Ruiter MB, Schagen SB.

Brain Imaging Behav. 2013 Dec;7(4):388-408. doi: 10.1007/s11682-013-9249-9. Review.

PMID:
23934234
12.

Breast cancer treatment and cognitive functioning: current status and future challenges in assessment.

Castellon SA, Silverman DH, Ganz PA.

Breast Cancer Res Treat. 2005 Aug;92(3):199-206. Review. No abstract available.

PMID:
16155790
13.

Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.

Hermelink K.

J Natl Cancer Inst Monogr. 2015 May;2015(51):67-9. doi: 10.1093/jncimonographs/lgv009. Review.

PMID:
26063891
14.

Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia.

Koppelmans V, Breteler MM, Boogerd W, Seynaeve C, Schagen SB.

Crit Rev Oncol Hematol. 2013 Oct;88(1):87-101. doi: 10.1016/j.critrevonc.2013.04.002. Epub 2013 Jun 13. Review.

PMID:
23768778
15.

Neural correlates of chemotherapy-related cognitive impairment.

Kaiser J, Bledowski C, Dietrich J.

Cortex. 2014 May;54:33-50. doi: 10.1016/j.cortex.2014.01.010. Epub 2014 Jan 30. Review.

PMID:
24632463
16.

Neuropsychologic testing for chemotherapy-related cognitive impairment.

Myers JS.

Adv Exp Med Biol. 2010;678:55-69. Review.

PMID:
20738007
17.

Predictors of cognitive decline in people with cancer undergoing chemotherapy.

Oh PJ.

Eur J Oncol Nurs. 2017 Apr;27:53-59. doi: 10.1016/j.ejon.2016.12.007. Epub 2016 Dec 24. Review.

PMID:
28027862
18.

Neurocognitive function in brain tumors.

Correa DD.

Curr Neurol Neurosci Rep. 2010 May;10(3):232-9. doi: 10.1007/s11910-010-0108-4. Review.

PMID:
20425039
19.

Alterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations.

McDonald BC, Saykin AJ.

Brain Imaging Behav. 2013 Dec;7(4):374-87. doi: 10.1007/s11682-013-9256-x. Review.

20.

Cognitive dysfunction after chemotherapy for breast cancer.

Edelstein K, Bernstein LJ.

J Int Neuropsychol Soc. 2014 Apr;20(4):351-6. doi: 10.1017/S1355617714000149. Epub 2014 Mar 24. Review. No abstract available.

PMID:
24655813

Supplemental Content

Support Center